ETC
GDRX icon

Exchange Traded Concepts’s GoodRx Holdings GDRX Stock Holding History

Exchange Traded Concepts’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-504
Closed -$20K – 1082
2020
Q4 		$20K Buy
+504
New +$23.2K ﹤0.01% 862

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
ZCI
Zevenbergen Capital Investments Edmonds, Washington $4.38B AUM 56.68% 1-Year Est. Return

Exchange Traded Concepts's GDRX Position: Q1 2021 in Review

Exchange Traded Concepts sold out of GoodRx Holdings (GDRX) in Q1 2021, closing a stake of 504 shares — an estimated $20K sold.

Exchange Traded Concepts first reported a position in GDRX in Q4 2020 and held it in 1 quarter. The position peaked at $20K in Q4 2020. 205 funds tracked by Wall St. Rank hold GDRX as of Q1 2021.

  • Exchange Traded Concepts reported no remaining GoodRx Holdings position as of Q1 2021 after selling out during the quarter.
  • Exchange Traded Concepts sold 504 GoodRx Holdings shares in Q1 2021, an estimated $20K.
  • Exchange Traded Concepts first reported a position in GoodRx Holdings in Q4 2020 and held it in 1 quarter.
  • Exchange Traded Concepts's GoodRx Holdings position peaked at $20K in Q4 2020.
  • 205 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2021.

Based on Exchange Traded Concepts's 13F filing for Q1 2021, filed 20 Apr 2021.